Gates Foundation – Visterra, Strategic Relationship Letter Agreement Post author:GHIAA Admin Post published:September 19, 2023 Post category: Continue ReadingGates Foundation – Visterra, Strategic Relationship Letter Agreement
NIH – UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement Post author:GHIAA Admin Post published:September 4, 2023 Post category: Continue ReadingNIH – UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement
PHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement Post author:GHIAA Admin Post published:September 1, 2023 Post category: Continue ReadingPHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement
PHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement Post author:GHIAA Admin Post published:August 30, 2023 Post category: Continue ReadingPHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement
PHS – Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement Post author:GHIAA Admin Post published:August 29, 2023 Post category: Continue ReadingPHS – Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement
PHS – Biosyn, HIV Prophylactic Exclusive License Agreement Post author:GHIAA Admin Post published:August 25, 2023 Post category: Continue ReadingPHS – Biosyn, HIV Prophylactic Exclusive License Agreement
DNDi Template Development Collaboration and License Agreement Post author:GHIAA Admin Post published:April 19, 2023 Post category: Continue ReadingDNDi Template Development Collaboration and License Agreement
DNDi Template Research Collaboration and License Agreement Post author:GHIAA Admin Post published:April 14, 2023 Post category: Continue ReadingDNDi Template Research Collaboration and License Agreement
BIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement Post author:GHIAA Admin Post published:March 3, 2023 Post category: Continue ReadingBIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement